Pain Relief Patches Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Report
250 Pages
November 2023
Region: Global
Fairfield Market Research
ID: 5908962

The global Pain Relief Patches Market, valued at $1.1 billion in 2024, is projected to expand significantly, reaching an estimated worth of $1.6 billion by 2031, with a CAGR of 5.50%. This growth is driven by a combination of pharmaceutical sciences and nanotechnology, which has paved the way for more effective chronic pain medications with fewer side effects. The integration of nanotechnology has played a pivotal role in boosting the sales of pain relief patches, with several nanomaterials authorized for medicinal use.

Nanotechnology Revolutionizing Pain Management:

The incorporation of nanotechnology in pain management has led to promising developments. A patented, non-invasive, and non-drug topical Kailo pain patch has been utilized in nanotechnology research to evaluate patients experiencing different levels of pain and their perceptions of pain management and associated symptoms. According to a study in the Anesthesia & Pain Research journal from December 2020, the Kailo pain patch led to a remarkable 71% reduction in the mean Brief Pain Inventory (BPI) severity, signifying a significant decrease in pain severity that interferes with daily functioning. Furthermore, 97% of patients reported reduced BPI severity when using the Kailo pain patch.

Manufacturers' Strategic Approaches:

Manufacturers of pain relief patches are strategically positioning themselves in response to changing market dynamics:

Cancer-Related Pain Management: The increasing prevalence of cancer is expected to drive the demand for pain relief patches, as chronic pain often accompanies cancer treatments. Manufacturers are focusing on developing technologically advanced devices to enhance the efficacy of pain relief patches for cancer patients, ensuring better quality of life during their treatment journey.
Transdermal Patches for Chronic Pain: Transdermal patches are emerging as an effective treatment option for chronic pain. This trend offers an opportunity for pain relief patch manufacturers to innovate and launch advanced devices that can deliver medications efficiently through the skin, improving pain management outcomes.

Challenges in the Pain Relief Patch Market:

Despite the market's potential, there are challenges to overcome:

Lack of Awareness: A significant hindrance to the widespread adoption of pain relief patches is the lack of awareness among the general population regarding their benefits and applications.
Allergic Reactions: Some individuals may develop allergic reactions to the adhesive glue used in pain relief patches, leading to contact dermatitis. This can limit the options available and hinder the sales of pain relief patches.
Latex Allergies: Latex, commonly used in pain relief patch production, can trigger allergic reactions in certain individuals, restricting their usage and impacting overall sales.

Country-wise Market Trends:

United States: The United States presents a lucrative market for pain relief patch manufacturers due to the increasing prevalence of car accidents, traumatic injuries, and chronic illnesses. Cancer-related pain management is also a significant driver for demand, with the FDA's approval of transdermal administration methods for specific treatments.

United Kingdom: In the UK, the growing use of opioids to manage pain stemming from trauma, injuries, severe illnesses, and post-surgical recovery is boosting the demand for pain relief patches. With millions of surgeries performed annually, the need for effective pain management options continues to rise.

China: China, accounting for a substantial share of the East Asian market, is experiencing a CAGR of 3.8% in pain relief patch sales through 2032. Initiatives by organizations like the Chinese Center for Disease Control and Prevention and the Chinese Society of Osteoporosis and Bone Mineral Research are raising awareness about musculoskeletal disorders and practical measures for their management.

Competition Landscape:

The global pain relief patch market is highly fragmented, with both local and major players competing for market share. To stay competitive, major market players are expanding their distribution channels to reach a broader customer base effectively.

Key Companies in the Market:

Viatris, Inc. (Mylan)
Johnson & Johnson Services, Inc.
Teva Pharmaceutical Industries Ltd.
Sanofi S.A.
Hisamitsu Pharmaceutical Co., Inc.
GlaxoSmithKline Plc.
Novartis AG
Nichiban Co., Ltd.
Teikoku Seiyaku Co, Ltd.
Mentholatum Company
Purdue Pharma L.P.
West-Ward Pharmaceuticals Corporation
Pfizer, Inc
Allergan PLC (Actavis)
Endo International PLC
Mylan N.V.
Corium, Inc.
Agile Therapeutics Inc.

Pain Relief Patches Industry Research Segmentation:

By Product Type:

Non-steroidal Anti-inflammatory Drug Patches

o Ketoprofen Patches:

o Diclofenac Patches:

o Flurbiprofen Patches:

o Piroxicam Patches:

Opioid Patches

o Fentanyl Patches:

o Buprenorphine Patches:

Local Anesthetic Patches

o Nitroglycerine Patches:

o Capsaicin Patches:

o Lidocaine Patches:

By Indication:

Menstrual Cramps
Orthopedic Pain
Neuropathic Pain
Post-operative Pain
Cardiovascular Pain
Others

By Distribution Channel:

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)

This product will be delivered within 1-3 business days.

1. Executive Summary

1.1. Global Pain Relief Patches Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Pain Relief Patches Market Outlook, 2018 - 2031

3.1. Global Pain Relief Patches Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Non-Steroidal Anti- Inflammatory Drug Patches
3.1.1.2. Ketroprofen Patches
3.1.1.3. Diclofenac Patches
3.1.1.4. Flurbiprofen Patches
3.1.1.5. Piroxicam Patches
3.1.1.6. Opioid Patches
3.1.1.7. Fentanyl Patches
3.1.1.8. Buprenorphine
3.1.1.9. Local Anaesthetic Patches
3.1.1.10. Nitro-glycerin Patches
3.1.1.11. Capsaicin Patches
3.1.1.12. Lidocaine Patches
3.2. Global Pain Relief Patches Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Menstrual Cramps
3.2.1.2. Orthopedic Pain
3.2.1.3. Neuropathic Pain
3.2.1.4. Post-Operative Pain
3.2.1.5. Cardiovascular Pain
3.2.1.6. Others
3.3. Global Pain Relief Patches Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. Hospital Pharmacies
3.3.1.2. Retail Pharmacies
3.3.1.3. Online Pharmacies
3.4. Global Pain Relief Patches Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
3.4.1. Key Highlights
3.4.1.1. North America
3.4.1.2. Europe
3.4.1.3. Asia Pacific
3.4.1.4. Latin America
3.4.1.5. Middle East & Africa

4. North America Pain Relief Patches Market Outlook, 2018 - 2031

4.1. North America Pain Relief Patches Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Non-Steroidal Anti- Inflammatory Drug Patches
4.1.1.2. Ketroprofen Patches
4.1.1.3. Diclofenac Patches
4.1.1.4. Flurbiprofen Patches
4.1.1.5. Piroxicam Patches
4.1.1.6. Opioid Patches
4.1.1.7. Fentanyl Patches
4.1.1.8. Buprenorphine
4.1.1.9. Local Anaesthetic Patches
4.1.1.10. Nitro-glycerin Patches
4.1.1.11. Capsaicin Patches
4.1.1.12. Lidocaine Patches
4.2. North America Pain Relief Patches Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Menstrual Cramps
4.2.1.2. Orthopedic Pain
4.2.1.3. Neuropathic Pain
4.2.1.4. Post-Operative Pain
4.2.1.5. Cardiovascular Pain
4.2.1.6. Others
4.3. North America Pain Relief Patches Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. Hospital Pharmacies
4.3.1.2. Retail Pharmacies
4.3.1.3. Online Pharmacies
4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Pain Relief Patches Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.4.1. Key Highlights
4.4.1.1. U.S. Pain Relief Patches Market by Product, Value (US$ Bn), 2018 - 2031
4.4.1.2. U.S. Pain Relief Patches Market by Indication, Value (US$ Bn), 2018 - 2031
4.4.1.3. U.S. Pain Relief Patches Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
4.4.1.4. Canada Pain Relief Patches Market by Product, Value (US$ Bn), 2018 - 2031
4.4.1.5. Canada Pain Relief Patches Market by Indication, Value (US$ Bn), 2018 - 2031
4.4.1.6. Canada Pain Relief Patches Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Pain Relief Patches Market Outlook, 2018 - 2031

5.1. Europe Pain Relief Patches Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Non-Steroidal Anti- Inflammatory Drug Patches
5.1.1.2. Ketroprofen Patches
5.1.1.3. Diclofenac Patches
5.1.1.4. Flurbiprofen Patches
5.1.1.5. Piroxicam Patches
5.1.1.6. Opioid Patches
5.1.1.7. Fentanyl Patches
5.1.1.8. Buprenorphine
5.1.1.9. Local Anaesthetic Patches
5.1.1.10. Nitro-glycerin Patches
5.1.1.11. Capsaicin Patches
5.1.1.12. Lidocaine Patches
5.2. Europe Pain Relief Patches Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Menstrual Cramps
5.2.1.2. Orthopedic Pain
5.2.1.3. Neuropathic Pain
5.2.1.4. Post-Operative Pain
5.2.1.5. Cardiovascular Pain
5.2.1.6. Others
5.3. Europe Pain Relief Patches Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Hospital Pharmacies
5.3.1.2. Retail Pharmacies
5.3.1.3. Online Pharmacies
5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Pain Relief Patches Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
5.4.1. Key Highlights
5.4.1.1. Germany Pain Relief Patches Market by Product, Value (US$ Bn), 2018 - 2031
5.4.1.2. Germany Pain Relief Patches Market by Indication, Value (US$ Bn), 2018 - 2031
5.4.1.3. Germany Pain Relief Patches Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.4.1.4. U.K. Pain Relief Patches Market by Product, Value (US$ Bn), 2018 - 2031
5.4.1.5. U.K. Pain Relief Patches Market by Indication, Value (US$ Bn), 2018 - 2031
5.4.1.6. U.K. Pain Relief Patches Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.4.1.7. France Pain Relief Patches Market by Product, Value (US$ Bn), 2018 - 2031
5.4.1.8. France Pain Relief Patches Market by Indication, Value (US$ Bn), 2018 - 2031
5.4.1.9. France Pain Relief Patches Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.4.1.10. Italy Pain Relief Patches Market by Product, Value (US$ Bn), 2018 - 2031
5.4.1.11. Italy Pain Relief Patches Market by Indication, Value (US$ Bn), 2018 - 2031
5.4.1.12. Italy Pain Relief Patches Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.4.1.13. Turkey Pain Relief Patches Market by Product, Value (US$ Bn), 2018 - 2031
5.4.1.14. Turkey Pain Relief Patches Market by Indication, Value (US$ Bn), 2018 - 2031
5.4.1.15. Turkey Pain Relief Patches Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.4.1.16. Russia Pain Relief Patches Market by Product, Value (US$ Bn), 2018 - 2031
5.4.1.17. Russia Pain Relief Patches Market by Indication, Value (US$ Bn), 2018 - 2031
5.4.1.18. Russia Pain Relief Patches Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.4.1.19. Rest of Europe Pain Relief Patches Market by Product, Value (US$ Bn), 2018 - 2031
5.4.1.20. Rest of Europe Pain Relief Patches Market by Indication, Value (US$ Bn), 2018 - 2031
5.4.1.21. Rest of Europe Pain Relief Patches Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Pain Relief Patches Market Outlook, 2018 - 2031

6.1. Asia Pacific Pain Relief Patches Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Non-Steroidal Anti- Inflammatory Drug Patches
6.1.1.2. Ketroprofen Patches
6.1.1.3. Diclofenac Patches
6.1.1.4. Flurbiprofen Patches
6.1.1.5. Piroxicam Patches
6.1.1.6. Opioid Patches
6.1.1.7. Fentanyl Patches
6.1.1.8. Buprenorphine
6.1.1.9. Local Anaesthetic Patches
6.1.1.10. Nitro-glycerin Patches
6.1.1.11. Capsaicin Patches
6.1.1.12. Lidocaine Patches
6.2. Asia Pacific Pain Relief Patches Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Menstrual Cramps
6.2.1.2. Orthopedic Pain
6.2.1.3. Neuropathic Pain
6.2.1.4. Post-Operative Pain
6.2.1.5. Cardiovascular Pain
6.2.1.6. Others
6.3. Asia Pacific Pain Relief Patches Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. Hospital Pharmacies
6.3.1.2. Retail Pharmacies
6.3.1.3. Online Pharmacies
6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Pain Relief Patches Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
6.4.1. Key Highlights
6.4.1.1. China Pain Relief Patches Market by Product, Value (US$ Bn), 2018 - 2031
6.4.1.2. China Pain Relief Patches Market by Indication, Value (US$ Bn), 2018 - 2031
6.4.1.3. China Pain Relief Patches Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.4.1.4. Japan Pain Relief Patches Market by Product, Value (US$ Bn), 2018 - 2031
6.4.1.5. Japan Pain Relief Patches Market by Indication, Value (US$ Bn), 2018 - 2031
6.4.1.6. Japan Pain Relief Patches Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.4.1.7. South Korea Pain Relief Patches Market by Product, Value (US$ Bn), 2018 - 2031
6.4.1.8. South Korea Pain Relief Patches Market by Indication, Value (US$ Bn), 2018 - 2031
6.4.1.9. South Korea Pain Relief Patches Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.4.1.10. India Pain Relief Patches Market by Product, Value (US$ Bn), 2018 - 2031
6.4.1.11. India Pain Relief Patches Market by Indication, Value (US$ Bn), 2018 - 2031
6.4.1.12. India Pain Relief Patches Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.4.1.13. Southeast Asia Pain Relief Patches Market by Product, Value (US$ Bn), 2018 - 2031
6.4.1.14. Southeast Asia Pain Relief Patches Market by Indication, Value (US$ Bn), 2018 - 2031
6.4.1.15. Southeast Asia Pain Relief Patches Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.4.1.16. Rest of Asia Pacific Pain Relief Patches Market by Product, Value (US$ Bn), 2018 - 2031
6.4.1.17. Rest of Asia Pacific Pain Relief Patches Market by Indication, Value (US$ Bn), 2018 - 2031
6.4.1.18. Rest of Asia Pacific Pain Relief Patches Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Pain Relief Patches Market Outlook, 2018 - 2031

7.1. Latin America Pain Relief Patches Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Non-Steroidal Anti- Inflammatory Drug Patches
7.1.1.2. Ketroprofen Patches
7.1.1.3. Diclofenac Patches
7.1.1.4. Flurbiprofen Patches
7.1.1.5. Piroxicam Patches
7.1.1.6. Opioid Patches
7.1.1.7. Fentanyl Patches
7.1.1.8. Buprenorphine
7.1.1.9. Local Anaesthetic Patches
7.1.1.10. Nitro-glycerin Patches
7.1.1.11. Capsaicin Patches
7.1.1.12. Lidocaine Patches
7.2. Latin America Pain Relief Patches Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
7.2.1.1. Hospital Pharmacies
7.2.1.2. Retail Pharmacies
7.2.1.3. Online Pharmacies
7.3. Latin America Pain Relief Patches Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Menstrual Cramps
7.3.1.2. Orthopedic Pain
7.3.1.3. Neuropathic Pain
7.3.1.4. Post-Operative Pain
7.3.1.5. Cardiovascular Pain
7.3.1.6. Others
7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Pain Relief Patches Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
7.4.1. Key Highlights
7.4.1.1. Brazil Pain Relief Patches Market by Product, Value (US$ Bn), 2018 - 2031
7.4.1.2. Brazil Pain Relief Patches Market by Indication, Value (US$ Bn), 2018 - 2031
7.4.1.3. Brazil Pain Relief Patches Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.4.1.4. Mexico Pain Relief Patches Market by Product, Value (US$ Bn), 2018 - 2031
7.4.1.5. Mexico Pain Relief Patches Market by Indication, Value (US$ Bn), 2018 - 2031
7.4.1.6. Mexico Pain Relief Patches Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.4.1.7. Argentina Pain Relief Patches Market by Product, Value (US$ Bn), 2018 - 2031
7.4.1.8. Argentina Pain Relief Patches Market by Indication, Value (US$ Bn), 2018 - 2031
7.4.1.9. Argentina Pain Relief Patches Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.4.1.10. Rest of Latin America Pain Relief Patches Market by Product, Value (US$ Bn), 2018 - 2031
7.4.1.11. Rest of Latin America Pain Relief Patches Market by Indication, Value (US$ Bn), 2018 - 2031
7.4.1.12. Rest of Latin America Pain Relief Patches Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Pain Relief Patches Market Outlook, 2018 - 2031

8.1. Middle East & Africa Pain Relief Patches Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Non-Steroidal Anti- Inflammatory Drug Patches
8.1.1.2. Ketroprofen Patches
8.1.1.3. Diclofenac Patches
8.1.1.4. Flurbiprofen Patches
8.1.1.5. Piroxicam Patches
8.1.1.6. Opioid Patches
8.1.1.7. Fentanyl Patches
8.1.1.8. Buprenorphine
8.1.1.9. Local Anaesthetic Patches
8.1.1.10. Nitro-glycerin Patches
8.1.1.11. Capsaicin Patches
8.1.1.12. Lidocaine Patches
8.2. Middle East & Africa Pain Relief Patches Market Outlook, by Indication, Value (US$ Bn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Menstrual Cramps
8.2.1.2. Orthopedic Pain
8.2.1.3. Neuropathic Pain
8.2.1.4. Post-Operative Pain
8.2.1.5. Cardiovascular Pain
8.2.1.6. Others
8.3. Middle East & Africa Pain Relief Patches Market Outlook, by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. Hospital Pharmacies
8.3.1.2. Retail Pharmacies
8.3.1.3. Online Pharmacies
8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Pain Relief Patches Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
8.4.1. Key Highlights
8.4.1.1. GCC Pain Relief Patches Market by Product, Value (US$ Bn), 2018 - 2031
8.4.1.2. GCC Pain Relief Patches Market by Indication, Value (US$ Bn), 2018 - 2031
8.4.1.3. GCC Pain Relief Patches Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.4.1.4. South Africa Pain Relief Patches Market by Product, Value (US$ Bn), 2018 - 2031
8.4.1.5. South Africa Pain Relief Patches Market by Indication, Value (US$ Bn), 2018 - 2031
8.4.1.6. South Africa Pain Relief Patches Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.4.1.7. Egypt Pain Relief Patches Market by Product, Value (US$ Bn), 2018 - 2031
8.4.1.8. Egypt Pain Relief Patches Market by Indication, Value (US$ Bn), 2018 - 2031
8.4.1.9. Egypt Pain Relief Patches Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.4.1.10. Nigeria Pain Relief Patches Market by Product, Value (US$ Bn), 2018 - 2031
8.4.1.11. Nigeria Pain Relief Patches Market by Indication, Value (US$ Bn), 2018 - 2031
8.4.1.12. Nigeria Pain Relief Patches Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.4.1.13. Rest of Middle East & Africa Pain Relief Patches Market by Product, Value (US$ Bn), 2018 - 2031
8.4.1.14. Rest of Middle East & Africa Pain Relief Patches Market by Indication, Value (US$ Bn), 2018 - 2031
8.4.1.15. Rest of Middle East & Africa Pain Relief Patches Market by Distribution Channel, Value (US$ Bn), 2018 - 2031
8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. By Distribution Channel vs by Indication Heat map
9.2. Manufacturer vs by Indication Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Viatris, Inc. (Mylan)
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Obalon Therapeutics, Inc.
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Johnson & Johnson Services, Inc.
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Teva Pharmaceutical Industries Ltd.
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Sanofi S.A.
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. Hisamitsu Pharmaceutical Co., Inc.
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. GlaxoSmithKline Plc.
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Novartis AG
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. Nichiban Co., Ltd.
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. Teikoku Seiyaku Co, Ltd.
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
9.5.11. Mentholatum Company.
9.5.11.1. Company Overview
9.5.11.2. Product Portfolio
9.5.11.3. Financial Overview
9.5.11.4. Business Strategies and Development
9.5.12. Purdue Pharma L.P.
9.5.12.1. Company Overview
9.5.12.2. Product Portfolio
9.5.12.3. Financial Overview
9.5.12.4. Business Strategies and Development
9.5.13. West-Ward Pharmaceuticals Corporation
9.5.13.1. Company Overview
9.5.13.2. Product Portfolio
9.5.13.3. Financial Overview
9.5.13.4. Business Strategies and Development
9.5.14. Pfizer, Inc
9.5.14.1. Company Overview
9.5.14.2. Product Portfolio
9.5.14.3. Financial Overview
9.5.14.4. Business Strategies and Development
9.5.15. Allergan Plc (Actavis)
9.5.15.1. Company Overview
9.5.15.2. Product Portfolio
9.5.15.3. Financial Overview
9.5.15.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Viatris, Inc. (Mylan)
Obalon Therapeutics, Inc.
Johnson & Johnson Services, Inc.
Teva Pharmaceutical Industries Ltd.
Sanofi S.A.
Hisamitsu Pharmaceutical Co., Inc.
GlaxoSmithKline Plc.
Novartis AG
Nichiban Co., Ltd.
Teikoku Seiyaku Co, Ltd.
Mentholatum Company.
Purdue Pharma L.P.
West-Ward Pharmaceuticals Corporation
Pfizer, Inc
Allergan Plc (Actavis)
Endo International plc,
Mylan N.V..Viatris, Inc.

Methodology

LOADING...